Mutations or alterations in GR protein levels are uncommon in primary leukaemia cells from GC-resistant patients [29] therefore suggesting that signalling pathways are likely to play a role in modulating GR phosphorylation and activity and in determining resistance or sensitivity to GCs induced apoptosis. The gene discussed is NR3C1; the disease is leukemia.